Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy.
about
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanismsIn vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18.The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.
P2860
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@ast
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@en
type
label
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@ast
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@en
prefLabel
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@ast
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@en
P2093
P2860
P356
P1476
Predictive value of the SLC22A ...... eceiving temozolomide therapy.
@en
P2093
Dong-Fu Feng
Pu-Cha Jiang
Sheng-Hua Chu
Yan-Bin Ma
Zhi-Qiang Li
P2860
P2888
P356
10.1186/1479-5876-11-69
P577
2013-03-20T00:00:00Z
P5875
P6179
1037565357